FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
| Location: | Maryland |
|---|---|
| Posted: | Jan 17, 2026 |
| Due: | Feb 24, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | FDABAA-26-00123 |
| Publication URL: | To access bid details, please log in. |
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Jan 16, 2026 07:42 am EST
- Original Published Date: Nov 21, 2025 08:57 am EST
- Updated Response Date: Feb 24, 2026 05:00 pm EST
- Original Response Date: Feb 24, 2026 11:59 pm EST
- Inactive Policy: Manual
- Updated Inactive Date: Sep 30, 2026
- Original Inactive Date: Sep 30, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
Silver Spring , MD 20993USA
Amendment 03 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
Amendment 02 - Save the date! the FY26 Virtual BAA day - 20 January 2026!
https://www.fda.gov/science-research/advancing-regulatory-science/2026-fda-broad-agency-announcement-day-01202026
Amendment 01 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
- 5630 Fishers Lane
- Rockville , MD 20857
- USA
- Ian Weiss
- Ian.Weiss@fda.hhs.gov
- Phone Number 3017965728
- Jan 16, 2026 07:42 am ESTSpecial Notice (Updated)
- Jan 06, 2026 08:54 am EST Special Notice (Updated)
- Dec 16, 2025 01:34 pm EST Special Notice (Updated)
- Nov 21, 2025 08:57 am EST Special Notice (Original)
Related Document
| Nov 21, 2025 | [Special Notice (Original)] FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science |
| Dec 16, 2025 | [Special Notice (Updated)] FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science |
| Jan 6, 2026 | [Special Notice (Updated)] FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science |
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... systems. Generative Unconstrained ...
DEPT OF DEFENSE
Bid Due: 10/18/2028
...Follow Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... Intelligence Drug Engineering ...
DEPT OF DEFENSE
Bid Due: 10/18/2028
...Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S... systems. Generative Unconstrained ...
DEPT OF DEFENSE
Bid Due: 10/18/2028
...-tier FOOD AND DRUG ADMINISTRATION Office FOOD AND DRUG ADMINISTRATION Looking for contract... ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 6/22/2026